VanEck Biotech ETF (NASDAQ:BBH) Sets New 12-Month High – Here’s What Happened

Posted by Jeff Wilder on Oct 21st, 2026

VanEck Biotech ETF (NASDAQ:BBH – Get Free Report)’s stock price hit a new 52-week high during trading on Wednesday. The stock traded as high as $248.78 and last traded at $248.78, with a volume of 13,301 shares traded. The stock had previously closed at $241.14.

VanEck Biotech ETF Stock Up 3.2%

The stock has a 50 day simple moving average of $237.34 and a two-hundred day simple moving average of $209.63.

Institutional Investors Weigh In On VanEck Biotech ETF

Several hedge funds have recently modified their holdings of BBH. Robertson Stephens Wealth Management LLC acquired a new stake in shares of VanEck Biotech ETF in the 3rd quarter worth $276,000. Cyndeo Wealth Partners LLC purchased a new stake in shares of VanEck Biotech ETF during the 3rd quarter worth approximately $318,000. Focus Financial Network Inc. purchased a new stake in VanEck Biotech ETF during the third quarter worth $240,000. BigSur Wealth Management LLC purchased a new stake in shares of VanEck Biotech ETF in the 3rd quarter worth about $126,000. Finally, Value Investment Professionals LLC purchased a new position in shares of VanEck Biotech ETF during the 3rd quarter worth approximately $333,000. 32.05% of the stock is owned by institutional investors and hedge funds.

VanEck Biotech ETF Company Profile

(Get Free Report)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.